ER Editor: The date of this article by Brian Shilhavy is April 24, 2021; the reporting period for vaccine deaths and injuries goes up to April 17, 2021.
Shilhavy credits a subscriber of his site for having compiled the information below. Isn’t it noteworthy that the EudraVigilance system does not have a simple, ready-to-access summary function?
Some countries seem especially hit by the incidence of adverse reactions, such as the Netherlands, France, Italy and Spain. Unfortunately, we have no way of knowing how these absolute numbers of harmful events translate into a percentage of the total number of vaccines given.
We don’t need to be reminded that these figures represent probably a tiny FRACTION of the total number of adverse events that have really happened.
********
7,766 DEAD 330,218 Injuries: European Database of Adverse Drug Reactions for COVID-19 “Vaccines”
BRIAN SHILHAVY
Editor, Health Impact News
The European database of suspected drug reaction reports is EudraVigilance, which also tracks reports of injuries and deaths following the experimental COVID-19 “vaccines.”
Here is what EudraVigilance states about their database:
This website was launched by the European Medicines Agency in 2012 to provide public access to reports of suspected side effects (also known as suspected adverse drug reactions). These reports are submitted electronically to EudraVigilance by national medicines regulatory authorities and by pharmaceutical companies that hold marketing authorisations (licences) for the medicines.
EudraVigilance is a system designed for collecting reports of suspected side effects. These reports are used for evaluating the benefits and risks of medicines during their development and monitoring their safety following their authorisation in the European Economic Area (EEA). EudraVigilance has been in use since December 2001.
This website was launched to comply with the EudraVigilance Access Policy, which was developed to improve public health by supporting the monitoring of the safety of medicines and to increase transparency for stakeholders, including the general public.
The Management Board of the European Medicines Agency first approved the EudraVigilance Access Policy in December 2010. A revision was adopted by the Board in December 2015 based on the 2010 pharmacovigilance legislation. The policy aims to provide stakeholders such as national medicines regulatory authorities in the EEA, the European Commission, healthcare professionals, patients and consumers, as well as the pharmaceutical industry and research organisations, with access to reports on suspected side effects.
Transparency is a key guiding principle of the Agency, and is pivotal to building trust and confidence in the regulatory process. By increasing transparency, the Agency is better able to address the growing need among stakeholders, including the general public, for access to information. (Source.)
Their report through April 17, 2021 lists 7,766 deaths and 330,218 injuries following injections of four experimental COVID-19 shots:
- COVID-19 MRNA VACCINE MODERNA (CX-024414)
- COVID-19 MRNA VACCINE PFIZER-BIONTECH
- COVID-19 VACCINE ASTRAZENECA (CHADOX1 NCOV-19)
- COVID-19 VACCINE JANSSEN (AD26.COV2.S)
A Health Impact News subscriber in Europe ran the reports for each of the four COVID-19 shots we are including here. This subscriber has volunteered to do this, and it is a lot of work to tabulate each reaction with injuries and fatalities, since there is no place on the EudraVigilance system we have found that tabulates all the results.
Here is the summary data through April 17, 2021.
Total reactions for the experimental mRNA vaccine Tozinameran (code BNT162b2, Comirnaty) from BioNTech/ Pfizer: 4,293 deaths and 144,607 injuries to 17/04/2021
- 10,754 Blood and lymphatic system disorders incl. 37 deaths
- 6,993 Cardiac disorders incl. 499 deaths
- 45 Congenital, familial and genetic disorders incl. 2 deaths
- 3,944 Ear and labyrinth disorders incl. 3 deaths
- 103 Endocrine disorders
- 4,388 Eye disorders incl. 5 deaths
- 32,024 Gastrointestinal disorders incl. 216 deaths
- 99,747 General disorders and administration site conditions incl. 1,397 deaths
- 199 Hepatobiliary disorders incl. 15 deaths
- 3,165 Immune system disorders incl. 19 deaths
- 9,534 Infections and infestations incl. 512 deaths
- 3,653 Injury, poisoning and procedural complications incl. 79 deaths
- 7,166 Investigations incl. 161 deaths
- 2,407 Metabolism and nutrition disorders incl. 85 deaths
- 51,699 Musculoskeletal and connective tissue disorders incl. 44 deaths
- 133 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 7 deaths
- 63,051 Nervous system disorders incl. 393 deaths
- 177 Pregnancy, puerperium and perinatal conditions incl. 7 deaths
- 76 Product issues
- 5,684 Psychiatric disorders incl. 60 deaths
- 885 Renal and urinary disorders incl. 62 deaths
- 911 Reproductive system and breast disorders incl. 1 death
- 13,181 Respiratory, thoracic and mediastinal disorders incl. 490 deaths
- 15,325 Skin and subcutaneous tissue disorders incl. 35 deaths
- 409 Social circumstances incl. 6 deaths
- 111 Vascular disorders incl. 152 deaths
Total reactions for the experimental mRNA vaccine mRNA-1273(CX-024414) from Moderna: 2,094 deaths and 15,979 injuries to 17/04/2021
- 766 Blood and lymphatic system disorders incl. 14 deaths
- 1,184 Cardiac disorders incl. 206 deaths
- 8 Congenital, familial and genetic disorders incl. 2 deaths
- 339 Ear and labyrinth disorders
- 20 Endocrine disorders
- 518 Eye disorders incl. 3 deaths
- 3,523 Gastrointestinal disorders incl. 75 deaths
- 11,366 General disorders and administration site conditions incl. 938 deaths
- 69 Hepatobiliary disorders incl. 3 deaths
- 439 Immune system disorders incl. 1 death
- 1,299 Infections and infestations incl. 107 deaths
- 707 Injury, poisoning and procedural complications incl. 41 deaths
- 5356 Investigations incl. 58 deaths
- 472 Metabolism and nutrition disorders incl. 42 deaths
- 5,163 Musculoskeletal and connective tissue disorders incl. 44 deaths
- 46 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 7 deaths
- 6,834 Nervous system disorders incl. 215 deaths
- 44 Pregnancy, puerperium and perinatal conditions
- 8 Product issues
- 782 Psychiatric disorders incl. 31 deaths
- 271 Renal and urinary disorders incl. 20 deaths
- 96 Reproductive system and breast disorders incl. 1 death
- 2,019 Respiratory, thoracic and mediastinal disorders incl. 181 deaths
- 1,947 Skin and subcutaneous tissue disorders incl. 19 deaths
- 151 Social circumstances incl. 6 deaths
- 100 Surgical and medical procedures incl. 12 deaths
- 1,035 Vascular disorders incl. 68 deaths
Total reactions for the experimental vaccine AZD1222/VAXZEVRIA (CHADOX1 NCOV-19) from Oxford/ AstraZeneca: 1,360 deaths and 169,386 injuries to 17/04/2021
- 4,740 Blood and lymphatic system disorders incl. 61 deaths
- 6,744 Cardiac disorders incl. 172 deaths
- 67 Congenital, familial and genetic disorders incl. 2 death
- 4,480 Ear and labyrinth disorders
- 127 Endocrine disorders incl. 2 deaths
- 6,983 Eye disorders incl. 5 deaths
- 52,560 Gastrointestinal disorders incl. 54 deaths
- 130,827 General disorders and administration site conditions incl. 442 deaths
- 203 Hepatobiliary disorders incl. 6 deaths
- 1,666 Immune system disorders incl. 6 deaths
- 9,789 Infections and infestations incl. 88 deaths
- 3,736 Injury, poisoning and procedural complications incl. 16 deaths
- 8,792 Investigations incl. 19 deaths
- 6,575 Metabolism and nutrition disorders incl. 14 deaths
- 76,467 Musculoskeletal and connective tissue disorders incl. 13 deaths
- 125 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 3 deaths
- 103,240 Nervous system disorders incl. 207 deaths
- 88 Pregnancy, puerperium and perinatal conditions
- 42 Product issues
- 8,740 Psychiatric disorders incl. 10 deaths
- 1,609 Renal and urinary disorders incl. 10 deaths
- 1,688 Reproductive system and breast disorders
- 14,224 Respiratory, thoracic and mediastinal disorders incl. 130 deaths
- 21,280 Skin and subcutaneous tissue disorders incl. 9 deaths
- 330 Social circumstances incl. 3 deaths
- 351 Surgical and medical procedures incl. 10 deaths
- 7,427 Vascular disorders incl. 78 deaths
Total reactions for the experimental COVID-19 vaccine JANSSEN (AD26.COV2.S) from Johnson & Johnson: 19 deaths and 246 injuries to 17/04/2021
(No graph yet)
- 9 Blood and lymphatic system disorders incl. 1 death
- 29 Cardiac disorders incl. 5 deaths
- 1 Congenital, familial and genetic disorder
- 16 Ear and labyrinth disorders
- 1 Endocrine disorder
- 14 Eye disorders
- 61 Gastrointestinal disorders
- 154 General disorders and administration site conditions incl. 8 deaths
- 4 Hepatobiliary disorders
- 10 Immune system disorders
- 27 Infections and infestations
- 16 Injury, poisoning and procedural complications
- 40 Investigations
- 12 Metabolism and nutrition disorders
- 59 Musculoskeletal and connective tissue disorders
- 0 Neoplasms benign, malignant and unspecified (incl cysts and polyps)
- 138 Nervous system disorders incl. 1 death
- 0 Pregnancy, puerperium and perinatal conditions
- 1 Product issue
- 24 Psychiatric disorders
- 9 Renal and urinary disorders incl. 1 death
- 4 Reproductive system and breast disorders
- 49 Respiratory, thoracic and mediastinal disorders incl. 1 death
- 28 Skin and subcutaneous tissue disorders
- 4 Social circumstances
- 4 Surgical and medical procedures
- 44 Vascular disorders incl. 2 deaths
This is public information funded by the European Medicines Agency (EMA), and anyone can use the EudraVigilance system and verify this data.
Denmark and Norway have completely suspended use of the AstraZeneca experimental COVID-19 shots.
A statement issued by the Norwegian Institute of Public Health stated that the AstraZeneca COVID “vaccine” is more dangerous than COVID itself, especially for young people.
The EMA continues to recommend it. They did, however, add a safety warning to the J&J shots, due to fatal blood clots. (Source.)
************
Source
Published to The Liberty Beacon from EuropeReloaded.com
••••
The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)
••••
Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.
••••
Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
••••
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.
Leave a Reply